-
Scientists Discover How Rapamycin Slows …
University of Montreal researchers have discovered a novel molecular mechanism that can … more…
-
New Screening Approach Uncovers …
Nearly two-thirds of patients with high-risk neuroblastoma —a common tumor that forms i … more…
-
Defective Cellular Waste Removal …
Gaucher disease causes debilitating and sometimes fatal neurodegeneration in early … more…
-
Breakthrough on Huntington's Disease
Researchers at Lund University have succeeded in preventing very early symptoms of … more…
-
Depression Common Among Children With …
A new study determined that children and adolescents with seizures involving the temporal … more…
-
Rare disease affects one in a million people (1)
-
NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival (1)
-
Doctor: ‘Probable’ case of rare, fatal disease third for area in recent months (1)
-
Has The Pendulum Swung Too Far in Favor of Rare Diseases? (1)
-
Quetiapine-Related Dysphagia (1)
Research News
Genetically Engineered Bacteria Prevent Mosquitoes From Transmitting Malaria
| More
Tuesday, July 17, 2012
Researchers at the Johns Hopkins Malaria Research Institute have genetically modified a bacterium commonly found in the mosquito's midgut and found that the parasite that causes malaria in people does not survive in mosquitoes carrying the modified bacterium.
The bacterium, Pantoea agglomerans, was modified to secrete proteins toxic to the malaria parasite, but the toxins do not harm the mosquito or humans. According to a study published by PNAS, the modified bacteria were 98 percent effective in reducing the malaria parasite burden in mosquitoes.
"In the past, we worked to genetically modify the mosquito to resist malaria, but genetic modification of bacteria is a simpler approach," said Marcelo Jacobs-Lorena, PhD, senior author of the study and a professor with Johns Hopkins Bloomberg School of Public Health. "The ultimate goal is to completely prevent the mosquito from spreading the malaria parasite to people."
With the study, Jacobs-Lorena and his colleagues found that the engineered P. agglomerans strains inhibited development of the deadliest human malaria parasite Plasmodium falciparum and rodent malaria parasite Plasmodium berghei by up to 98 percent within the mosquito. The proportion of mosquitoes carrying parasites (prevalence) decreased by up to 84 percent.
"We demonstrate the use of an engineered symbiotic bacterium to interfere with the development of P. falciparum in the mosquito. These findings provide the foundation for the use of genetically modified symbiotic bacteria as a powerful tool to combat malaria," said Jacobs-Lorena.
Malaria kills more than 800,000 people worldwide each year. Many are children.
The authors of "Fighting malaria with engineered symbiotic bacteria from vector mosquitoes" are Sibao Wang, Anil K. Ghosh, Nicholas Bongio, Kevin A. Stebbings, David J. Lampe and Marcelo Jacobs-Lorena.
The research was supported by National Institute of Allergy and Infectious Diseases, the Bill & Melinda Gates Foundation, the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation.
Follow the Johns Hopkins Bloomberg School of Public Health on Facebook at http://www.facebook.com/JohnsHopkinsSPH and Twitter at http://www.twitter.com/JohnsHopkinsSPH.
Contact:Tim Parsonstmparson@jhsph.edu
410-955-7619
Source: Johns Hopkins University Bloomberg School of Public Health
Log in now to comment.